T2 Biosystems, Inc.

( )
TTOO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -6.60%123.470.0%$1121.14m
OCGNOcugen, Inc. -1.26%8.630.0%$797.67m
AMGNAmgen, Inc. 0.04%227.811.3%$546.41m
REGNRegeneron Pharmaceuticals, Inc. 0.35%463.192.7%$534.62m
NVAXNovavax, Inc. -9.71%157.8792.9%$533.68m
GILDGilead Sciences, Inc. 0.20%64.751.0%$502.19m
ILMNIllumina, Inc. -3.82%383.623.5%$481.24m
VRTXVertex Pharmaceuticals, Inc. 0.76%213.581.9%$461.68m
ALXNAlexion Pharmaceuticals, Inc. -0.03%150.062.0%$329.21m
BNGOBioNano Genomics, Inc. 8.67%7.770.0%$322.31m
CRSPCRISPR Therapeutics AG -0.90%113.620.6%$321.43m
BIIBBiogen, Inc. -0.26%270.011.7%$296.77m
EXASEXACT Sciences Corp. -4.17%116.5718.4%$244.18m
SGENSeagen Inc. -0.45%148.685.8%$208.59m
PACBPacific Biosciences of California, Inc. -6.49%27.377.2%$176.05m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.